Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health, Inc. (NYSE: EVH) plays a pivotal role in the healthcare sector by supporting health systems and physician organizations in their transition to value-based care and population health management. Headquartered in Arlington, Virginia, Evolent is backed by major entities such as The Advisory Board Company, University of Pittsburgh Medical Center Health Plan, and TPG Growth. The company’s core business revolves around providing integrated specialty care management services, total cost of care management, and health plan administration through an all-inclusive platform.
Evolent specializes in managing complex conditions in fields such as oncology, cardiology, and musculoskeletal markets, aiming to simplify healthcare and make it more affordable. The company's recent achievements include exceeding profitability expectations in the third quarter of 2023, adding new operating partnerships, and enhancing its financial outlook for the year. Evolent reported robust financial health with $184.5 million in cash and cash equivalents as of September 30, 2023.
The company’s culture is centered around collaboration, innovation, and a supportive work environment. Benefits like treadmill desks, healthy snacks, and wellness challenges underscore its commitment to employee well-being.
Notably, Evolent is also venturing into AI-driven healthcare solutions, as evidenced by its recent agreement to acquire Machinify Auth, a software platform that enhances clinical quality through advanced AI. This acquisition is expected to significantly improve the speed and efficiency of clinical reviews for various conditions.
In summary, Evolent Health continues to be a significant player in the healthcare industry, driving better health outcomes and financial performance through innovative solutions.
Evolent Health has announced a definitive agreement to acquire IPG, a provider of surgical management solutions for musculoskeletal conditions, for $375 million plus up to $87 million in contingent consideration. The acquisition aims to enhance Evolent's position in value-based specialty care and is expected to be immediately accretive to Adjusted EBITDA margins and cash flow. The integration will diversify Evolent’s customer mix and provide valuable relationships with national commercial health plans.
Evolent Health, Inc. (NYSE: EVH) has announced that its CEO Seth Blackley, CFO John Johnson, and VP of Investor Relations Seth Frank will participate in several investor conferences in May and June 2022. The events include presentations at the BofA Securities Health Care Conference on May 12, RBC Capital Markets Global Healthcare Conference on May 17, and the 42nd Annual Growth Stock Conference on June 6. Additionally, Johnson and Frank will attend the J.P. Morgan Healthcare Services Summit on June 21, which will not be webcasted. Live webcasts will be available on the company's Investor Relations website.
Evolent Health, Inc. (NYSE: EVH) reported Q1 2022 revenues of $297.1 million, up 38.1% YoY, with net losses of $5.4 million. Adjusted EBITDA reached $24.3 million, yielding an 8.2% margin. Total lives on the platform stood at 20.3 million. The company announced new partnerships, including AvMed's expansion into oncology services and Bright Healthcare's member increase for 2023. For Q2 2022, revenue guidance is set at $290.0 million to $305.0 million, while full-year revenue is projected between $1.16 billion and $1.21 billion.
Evolent Health (NYSE: EVH) will announce its first quarter 2022 operating results on May 4, 2022, after the market closes. A conference call will follow at 5:00 p.m. Eastern Time. Interested shareholders can access the live broadcast by calling 855.940.9467 or 412.317.6034 (international). An audio playback will be available for 30 days on the company's investor relations website. Evolent Health provides clinical and administrative solutions to enhance healthcare delivery, serving a national network of leading payers and providers.
New Century Health (NCH) reported that its partner, Cancer Care Specialists (CCSI) of Illinois, earned nearly
Evolent Health, Inc. (NYSE: EVH) announced participation in two upcoming investor conferences. Chief Financial Officer John Johnson and Vice President of Investor Relations Seth Frank will present at the 42nd Annual Cowen Health Care Conference on March 7, 2022, at 9:10 a.m. ET, and at the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2022, at 9:00 a.m. ET. Live audio webcasts will be available on Evolent's investor relations website, with replays accessible shortly after the events.
Evolent Health (NYSE: EVH) reported Q4 and full-year financial results for 2021, showcasing GAAP revenue of $248.4 million, a slight increase of 0.7% year-over-year. In contrast, full-year revenue fell by 1.8% to $908.0 million. Notably, revenue excluding divested assets grew by 39.7% and 36.7% for Q4 and the full year, respectively. Despite a net loss of $(5.6) million in Q4 and $(37.6) million for 2021, Evolent achieved an Adjusted EBITDA of $24.3 million for Q4 and $66.3 million for the year. The company also announced new partnerships, enhancing its service delivery.
Evolent Health (NYSE: EVH) has announced it will disclose its fourth quarter and full year 2021 operating results on February 23, 2022, after market close. Following the release, a conference call is scheduled at 5:00 p.m. Eastern Time. Participants can access the call by dialing 855.940.9467 or 412.317.6034 for international listeners, referencing the "Evolent Health call". An audio playback will be available on the company's investor relations website for one week after the event.
Evolent Health (NYSE: EVH) announced a partnership with PCG Consulting Group to establish a customer contact team in Cook County, Illinois, serving over 400,000 Medicaid members. This collaboration aims to enhance diversity and support minority communities. PCG, with 79% of its employees from underserved areas, provides crucial administrative and clinical services. The initiative aligns with Evolent's commitment to health equity and improving member experiences, particularly for Black and African American individuals in the area. The partnership is part of Evolent's broader strategy to promote diversity and community engagement.
FAQ
What is the current stock price of Evolent Health (EVH)?
What is the market cap of Evolent Health (EVH)?
What is the primary business of Evolent Health, Inc.?
Where is Evolent Health headquartered?
What recent financial achievements has Evolent Health reported?
What are some of the core services provided by Evolent Health?
What recent acquisition did Evolent Health announce?
Who are some of the backers of Evolent Health?
What are the primary specialty care areas Evolent focuses on?
How does Evolent Health view its company culture?
What is the significance of Evolent’s acquisition of Machinify Auth?
How has Evolent Health performed financially in recent quarters?
